Investor Summit Virtual Conference
Logotype for Nano-X Imaging Ltd

Nano-X Imaging (NNOX) Investor Summit Virtual Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Nano-X Imaging Ltd

Investor Summit Virtual Conference summary

25 Mar, 2026

Company overview and product strategy

  • Provides an end-to-end imaging solution from scan to diagnosis, aiming to enhance diagnostic capabilities for patients.

  • Core product is the Nanox.ARC, a digital multi-source 3D tomosynthesis imaging system, with both first and second generation devices (ARC and ARC X) FDA-cleared.

  • Recent acquisition of VasoHealthcare IT expands the AI and software division, integrating PACS and teleradiology offerings.

  • Commercialization began in the U.S. in 2023, with European commercialization starting in 2024; direct and indirect sales models in the U.S., indirect (distributor) model elsewhere.

  • Focuses on imaging centers, urgent care, orthopedic, and multipurpose clinics to avoid direct competition with larger industry players.

Technology and innovation

  • Proprietary silicon-based, low-voltage, nanoscale cold cathode chip powers the imaging devices, offering cost and operational advantages over traditional X-ray technology.

  • Second generation tubes use glass instead of ceramic, reducing size and complexity; devices are compact, lightweight, and require minimal installation space.

  • Multi-source, multi-axis design enables rapid 3D imaging with lower radiation and power requirements compared to CT.

  • Cloud-based reconstruction software creates 3D images from 30-60 2D scans in under 12 seconds.

  • Devices are easy to operate, maintain, and integrate with existing PACS systems; remote monitoring and updates are provided.

AI and software solutions

  • AI tools are FDA and CE approved, supporting early detection of asymptomatic chronic diseases and preventative management.

  • AI division offers solutions for coronary artery calcium scoring, spinal measurement (HealthOST), bone mineral density, and liver disease detection.

  • Largest AI customer is Spectrum Health, now in its fifth year; new B2B2C models are being piloted with diagnostic centers.

  • Acquisition of VasoHealthcare IT enables cross-selling of PACS software and a more comprehensive solution suite.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more